+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

LAMEA Cyclodextrin Market Size, Share & Trends Analysis Report By Type (Beta-Cyclodextrin, Alpha-Cyclodextrin, and Gamma-Cyclodextrin), By End-use, By Country and Growth Forecast, 2024 - 2031

  • PDF Icon

    Report

  • 116 Pages
  • April 2024
  • Region: Africa, Middle East
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5972503
The Latin America, Middle East and Africa Cyclodextrin Market would witness market growth of 7.3% CAGR during the forecast period (2024-2031). In the year 2027, the LAMEA market's volume is expected to surge to 88.13 Tonnes, showcasing a growth of 4.8% (2024-2031).

In the food industry, cyclodextrins serve various essential roles due to their versatile properties. These chemicals, including alpha-, beta-, and gamma-variants, find applications in food products as encapsulating agents for volatile flavors and aromas, masking undesirable tastes or odors. They stabilize food additives like colors, flavors, and antioxidants, prolonging their shelf life and ensuring product consistency. Therefore, the Brazil market utilized 4.78 Tonnes of cyclodextrins in food industry in 2023.



The Brazil market dominated the LAMEA Cyclodextrin Market by Country in 2023 and would continue to be a dominant market till 2031; thereby, achieving a market value of $10,037.1 Thousands by 2031. The Argentina market is showcasing a CAGR of 7.9% during (2024 - 2031). Additionally, The UAE market would register a CAGR of 6.9% during (2024 - 2031).

The adoption of cyclodextrins has steadily increased across various industries, driven by their unique properties and versatile applications. The widespread adoption of these can be attributed to several factors. Pharmaceutical companies have increasingly adopted these chemicals as excipients in drug formulations to overcome the challenges of low aqueous solubility, thereby enhancing drug delivery and therapeutic efficacy.

Cyclodextrins are used in pharmaceuticals and food products to mask active ingredients’ unpleasant taste and odour. By encapsulating volatile or bitter compounds, these improve the palatability and consumer acceptance of oral medications, dietary supplements, and functional foods. The adoption of these has also been driven by the demand for targeted drug delivery systems that enable site-specific delivery of therapeutics while minimizing systemic side effects.

The expansion of the chemical industry in the UAE can create opportunities for the production of specialty chemicals, including these chemicals. Local chemical manufacturers may explore the production of these and their derivatives to cater to specific industrial needs. Therefore, the expansion of the food and beverage industry and the rising chemical industry in the region are driving the market’s growth.

Based on Type, the market is segmented into Beta-Cyclodextrin, Alpha-Cyclodextrin, and Gamma-Cyclodextrin. Based on End-use, the market is segmented into Pharmaceutical, Food, Cosmetics & Personal Care, Chemical, Textile and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.

List of Key Companies Profiled

  • Midas Pharma Gmbh
  • Wacker Chemie AG
  • Roquette Freres SA
  • Cambrex Corporation
  • Wellona Pharma
  • Cayman Chemical Company, Inc.
  • Cyclolab Kft.
  • Ligand Pharmaceuticals Incorporated
  • Tocopharm Co. Limited
  • Merck KGaA

Market Report Segmentation

By Type (Volume, Tonnes, USD Million, 2020-2031)
  • Beta-Cyclodextrin
  • Alpha-Cyclodextrin
  • Gamma-Cyclodextrin
By End-use (Volume, Tonnes, USD Million, 2020-2031)
  • Pharmaceutical
  • Food
  • Cosmetics & Personal Care
  • Chemical
  • Textile
  • Others
By Country (Volume, Tonnes, USD Million, 2020-2031)
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Cyclodextrin Market, by Type
1.4.2 LAMEA Cyclodextrin Market, by End-use
1.4.3 LAMEA Cyclodextrin Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Opportunities
3.2.3 Market Restraints
3.2.4 Market Challenges
3.3 Porter Five Forces Analysis
Chapter 4. LAMEA Cyclodextrin Market by Type
4.1 LAMEA Beta-Cyclodextrin Market by Country
4.2 LAMEA Alpha-Cyclodextrin Market by Country
4.3 LAMEA Gamma-Cyclodextrin Market by Country
Chapter 5. LAMEA Cyclodextrin Market by End-use
5.1 LAMEA Pharmaceutical Market by Country
5.2 LAMEA Food Market by Country
5.3 LAMEA Cosmetics & Personal Care Market by Country
5.4 LAMEA Chemical Market by Country
5.5 LAMEA Textile Market by Country
5.6 LAMEA Others Market by Country
Chapter 6. LAMEA Cyclodextrin Market by Country
6.1 Brazil Cyclodextrin Market
6.1.1 Brazil Cyclodextrin Market by Type
6.1.2 Brazil Cyclodextrin Market by End-use
6.2 Argentina Cyclodextrin Market
6.2.1 Argentina Cyclodextrin Market by Type
6.2.2 Argentina Cyclodextrin Market by End-use
6.3 UAE Cyclodextrin Market
6.3.1 UAE Cyclodextrin Market by Type
6.3.2 UAE Cyclodextrin Market by End-use
6.4 Saudi Arabia Cyclodextrin Market
6.4.1 Saudi Arabia Cyclodextrin Market by Type
6.4.2 Saudi Arabia Cyclodextrin Market by End-use
6.5 South Africa Cyclodextrin Market
6.5.1 South Africa Cyclodextrin Market by Type
6.5.2 South Africa Cyclodextrin Market by End-use
6.6 Nigeria Cyclodextrin Market
6.6.1 Nigeria Cyclodextrin Market by Type
6.6.2 Nigeria Cyclodextrin Market by End-use
6.7 Rest of LAMEA Cyclodextrin Market
6.7.1 Rest of LAMEA Cyclodextrin Market by Type
6.7.2 Rest of LAMEA Cyclodextrin Market by End-use
Chapter 7. Company Profiles
7.1 Midas Pharma GmbH
7.1.1 Company Overview
7.2 Wacker Chemie AG
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 Recent strategies and developments:
7.2.5.1 Acquisition and Mergers:
7.2.6 SWOT Analysis
7.3 Roquette Freres SA
7.3.1 Company Overview
7.3.2 Recent strategies and developments:
7.3.2.1 Partnerships, Collaborations, and Agreements:
7.3.3 SWOT Analysis
7.4 Cambrex Corporation
7.4.1 Company Overview
7.4.2 SWOT Analysis
7.5 Wellona Pharma
7.5.1 Company Overview
7.6 Cayman Chemical Company, Inc.
7.6.1 Company Overview
7.6.2 SWOT Analysis
7.7 Cyclolab Kft.
7.7.1 Company Overview
7.8 Ligand Pharmaceuticals Incorporated
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Research & Development Expenses
7.9 Tocopharm Co. Limited
7.9.1 Company Overview
7.10. Merck KGaA
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expense
7.10.5 SWOT Analysis

Companies Mentioned

  • Midas Pharma Gmbh
  • Wacker Chemie AG
  • Roquette Freres SA
  • Cambrex Corporation
  • Wellona Pharma
  • Cayman Chemical Company, Inc.
  • Cyclolab Kft.
  • Ligand Pharmaceuticals Incorporated
  • Tocopharm Co. Limited
  • Merck KGaA

Methodology

Loading
LOADING...